ZIMMER BIOMET HOLDINGS, INC. Derivative Asset, Fair Value, Gross Asset
ZIMMER BIOMET HOLDINGS, INC. (ZBH) had Derivative Asset, Fair Value, Gross Asset of $86.20 million as of 2021-12-31, per its 10-K filed 2023-02-24.
Discontinued › Notes
us-gaap:DerivativeFairValueOfDerivativeAsset · last filed 2023-02-24
- 2021-12-31: Derivative Asset, Fair Value, Gross Asset $86.20M.
- 2020-12-31: Derivative Asset, Fair Value, Gross Asset $15.90M.
| Period end | Derivative Asset, Fair Value, Gross Asset |
|---|---|
| 2021-12-31 | $86.20M 10-K · filed 2023-02-24 |
| 2020-12-31 | $15.90M 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |